The cytotoxicity of Tynen®, the LsbMDDs, and BsAbs-LsbMDDs against the HER2-positive (MCF-7/HER2 and SKBR-3) and HER2-negative (MCF-7) cancer cells was examined. Here, ERBB2 is linked to cancer.